FAS
CVS icon

Formuepleje A/S’s CVS Health CVS Stock Holding History

Formuepleje A/S’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-139,008
Closed -$11.1M – 67
2024
Q1 		$11.1M Sell
139,008
-13,219
-9% -$1.01M 0.63% 46
2023
Q4 		$12M Sell
152,227
-8,070
-5% -$574K 0.85% 33
2023
Q3 		$11.2M Buy
160,297
+11,464
+8% +$812K 1.04% 27
2023
Q2 		$10.3M Buy
148,833
+23,223
+18% +$1.65M 0.9% 32
2023
Q1 		$9.33M Buy
125,610
+10,036
+9% +$842K 0.68% 42
2022
Q4 		$10.8M Buy
115,574
+59,441
+106% +$5.74M 0.91% 31
2022
Q3 		$5.35M Buy
+56,133
New +$5.56M 0.43% 54
2018
Q1 		– Sell
-122,472
Closed -$8.88M – 65
2017
Q4 		$8.88M Buy
122,472
+3,872
+3% +$282K 0.91% 29
2017
Q3 		$9.64M Sell
118,600
-1,200
-1% -$94.9K 1.06% 30
2017
Q2 		$9.64M Sell
119,800
-600
-0.5% -$47.4K 1% 31
2017
Q1 		$9.45M Hold
120,400
– – 1.13% 29
2016
Q4 		$9.5M Buy
+120,400
New +$9.74M 1.25% 24

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Formuepleje A/S's CVS Position: Q2 2024 in Review

Formuepleje A/S sold out of CVS Health (CVS) in Q2 2024, closing a stake of 139,008 shares — an estimated $11.1M sold.

Formuepleje A/S first reported a position in CVS in Q4 2016 and held it in 12 quarters. The position peaked at $12M in Q4 2023. 1,914 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Formuepleje A/S reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Formuepleje A/S sold 139,008 CVS Health shares in Q2 2024, an estimated $11.1M.
  • Formuepleje A/S first reported a position in CVS Health in Q4 2016 and held it in 12 quarters.
  • Formuepleje A/S's CVS Health position peaked at $12M in Q4 2023.
  • 1,914 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Formuepleje A/S's 13F filing for Q2 2024, filed 27 Aug 2026.